The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing.
Kinetoplastid parasites-trypanosomes and leishmanias-infect millions of humans and cause economically devastating diseases of livestock, and the few existing drugs have serious deficiencies. Benzoxaborole-based compounds are very promising potential novel anti-trypanosomal therapies, with candidates...
Guardado en:
Autores principales: | Daniela Begolo, Isabel M Vincent, Federica Giordani, Ina Pöhner, Michael J Witty, Timothy G Rowan, Zakaria Bengaly, Kirsten Gillingwater, Yvonne Freund, Rebecca C Wade, Michael P Barrett, Christine Clayton |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e1674f3ac3f24f8baaf483e779b5f349 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
por: Christopher S. Lunde, et al.
Publicado: (2019) -
A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue
por: Ebere Sonoiki, et al.
Publicado: (2017) -
Cytotoxicity and trypanocidal activity of nifurtimox encapsulated in ethylcyanoacrylate nanoparticles
por: SÁNCHEZ,GITTITH, et al.
Publicado: (2002) -
Modeling the control of trypanosomiasis using trypanocides or insecticide-treated livestock.
por: John W Hargrove, et al.
Publicado: (2012) -
Cyclical appearance of African trypanosomes in the cerebrospinal fluid: new insights in how trypanosomes enter the CNS.
por: Stefan Mogk, et al.
Publicado: (2014)